Search | TVST | ARVO Journals

View

Showing 1 – 7 of 7

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Clinical Trials January 2022

Tie2 Activation via VE-PTP Inhibition With Razuprotafib as an Adjunct to Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension

PDF

Mitchell Brigell; Barbara Withers; Akshay Buch; Kevin G. Peters
TAGS: intraocular pressure, latanoprost, ocular hypertension, open-angle glaucoma, conjunctival injection
Trans. Vis. Sci. Tech.. 2022; 11(1):7. https://doi.org/10.1167/tvst.11.1.7

Includes: Supplemental Content

Physiology and Pharmacology December 2020

A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure

PDF

Guorong Li; Astrid F. Nottebaum; Mitchell Brigell; Iris D. Navarro; Ute Ipe; Sarthak Mishra; Maria Gomez-Caraballo; Heather Schmitt; Brandi Soldo; Steve Pakola; Barbara Withers; Kevin G. Peters; Dietmar Vestweber; W. Daniel Stamer

Invest. Ophthalmol. Vis. Sci.. 2020; 61(14):12. https://doi.org/10.1167/iovs.61.14.12

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

OCTA metrics in the macula and optic nerve head predict diabetic retinopathy disease progression

Eugenia Paula Custo Greig; Mitchell G Brigell; Barbara Withers; Kevin G Peters; Eric Moult; James G Fujimoto; Nadia K Waheed

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4039.

ARVO Annual Meeting Abstract July 2019

By targeting Tie2/VE-PTP in Schlemm’s canal, AKB-9778 lowers intraocular pressure via increasing outflow facility in mice

W Daniel Stamer; Guorong Li; Iris D Navarro; Astrid Nottebaum; Dietmar Vestweber; Kevin G Peters

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2186.

ARVO Annual Meeting Abstract July 2018

Subcutaneous Administration of AKB-9778, a Tie2 Activator, Reduces IOP in Patients with Diabetic Retinopathy

Mitchell G Brigell; Victor H Gonzalez; Darren J Bell; Arshad M. Khanani; Barbara Withers; Laura Gambino; Peter A Campochiaro; Kevin G Peters; Steve Pakola

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1252.

ARVO Annual Meeting Abstract July 2018

A VE-PTP Antibody Activates Tie2 and Suppresses VEGF-Induced Retinal Vascular Leakage

Kevin G Peters; Ji-kui Shen; Yuanyuan liu; Astrid Nottebaum; Dietmar Vestweber; Michael Flynn; Peter A Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):199.

ARVO Annual Meeting Abstract July 2018

Topical or Subcutaneous Administration of AKB-9778, a Tie2 Activator, Reduces IOP in NZW Rabbits

Glenwood G Gum; John Janusz; Brandi Soldo; Brian Walker; Akshay Buch; Steve Pakola; Kevin G Peters

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2719.

Advertisement